1 November 2024 in International Journal of Innovative Research in Medical Science
An 80-year-old male, autonomous, with a history of cardiovascular risk factors, underwent aortic bioprosthesis placement for symptomatic severe aortic stenosis. He presented with acute bacterial endocarditis of the aortic valve prosthesis caused by methicillin-resistant Staphylococcus epidermidis (MRSE). The patient also had a pacemaker for atrial fibrillation and required catheter replacement due to infectious vegetation. Admitted one year after a previous episode of bacterial endocarditis, he exhibited fever of unknown origin, prostration, anorexia, and elevated inflammatory markers. Empirical treatment was initiated with ceftriaxone, gentamicin, and vancomycin. Hemocultures revealed Candida metapsilosis, leading to the addition of caspofungin. Transesophageal echocardiography showed vegetations on the bioprosthesis but none on the pacemaker catheter. He spent 103 days in the hospital, including intensive care for renal dysfunction. Following persistent fungemia, antifungal therapy was switched to liposomal amphotericin B. Haemocultures were sterilized 38 days after treatment initiation. The patient was discharged on lifelong itraconazole, with no periprosthetic complications, highlighting a rare case of recurrent fungal endocarditis following bacterial infection.
26 September 2024 in International Journal of Innovative Research in Medical Science
We present a case of Q fever in a 77-year-old autonomous male with a complex medical history. The patient, immunocompromised due to azathioprine and prednisolone use for myasthenia gravis, also suffered from diabetes mellitus, heart failure, and severe asthma. Despite no history of animal contact or travel to endemic regions, the patient developed flu-like symptoms followed by high fever and prostration. Multiple courses of antibiotics were administered without clinical improvement, and cultures of blood, urine, and stool were negative. Serological testing for Coxiella burnetii confirmed the diagnosis, with positive IgG and IgM phase II antibodies. The patient received doxycycline therapy and experienced rapid clinical improvement, with sustained apyrexy and no recurrence of symptoms at a 2-week follow-up. This case highlights the diagnostic challenges of Q fever, particularly in immunocompromised individuals with multiple comorbidities. Despite the absence of typical exposure history, serological testing was crucial for confirming the diagnosis. The timely initiation of doxycycline therapy was essential for a favourable outcome.